GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (AMEX:CCEL) » Definitions » Scaled Net Operating Assets

Cryo-Cell International (Cryo-Cell International) Scaled Net Operating Assets

: 0.00 (As of Feb. 2024)
View and export this data going back to . Start your Free Trial

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Cryo-Cell International's operating assets for the quarter that ended in Feb. 2024 was $60.73 Mil. Cryo-Cell International's operating liabilities for the quarter that ended in Feb. 2024 was $60.49 Mil. Cryo-Cell International's Total Assets for the quarter that ended in Nov. 2023 was $61.22 Mil. Therefore, Cryo-Cell International's scaled net operating assets (SNOA) for the quarter that ended in Feb. 2024 was 0.00.


Cryo-Cell International Scaled Net Operating Assets Historical Data

The historical data trend for Cryo-Cell International's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryo-Cell International Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Scaled Net Operating Assets
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.16 -0.03 0.14 -0.02

Cryo-Cell International Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Scaled Net Operating Assets Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.14 0.16 -0.02 -

Competitive Comparison

For the Medical Care Facilities subindustry, Cryo-Cell International's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International Scaled Net Operating Assets Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's Scaled Net Operating Assets falls into.



Cryo-Cell International Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Cryo-Cell International's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Nov. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Nov. 2023 )
=(Operating Assets (A: Nov. 2023 )-Operating Liabilities (A: Nov. 2023 ))/Total Assets (A: Nov. 2022 )
=(60.241-61.356)/64.888
=-0.02

where

Operating Assets(A: Nov. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=61.221 - 0.98
=60.241

Operating Liabilities(A: Nov. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=72.252 - 9.282 - 1.614
=61.356

Cryo-Cell International's Scaled Net Operating Assets (SNOA) for the quarter that ended in Feb. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Feb. 2024 )
=(Operating Assets (Q: Feb. 2024 )-Operating Liabilities (Q: Feb. 2024 ))/Total Assets (Q: Nov. 2023 )
=(60.731-60.493)/61.221
=0.00

where

Operating Assets(Q: Feb. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=61.711 - 0.98
=60.731

Operating Liabilities(Q: Feb. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=72.049 - 9.161 - 2.395
=60.493

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cryo-Cell International Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Cryo-Cell International's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryo-Cell International (Cryo-Cell International) Business Description

Traded in Other Exchanges
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Executives
David Portnoy director, officer: Co-Chief Executive Officer C/O FOCUS FINANCIAL GROUP, 61 HARBOUR WAY, BAL HARBOUR FL 33154
George Gaines director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Jonathan H. Wheeler director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Brian L. Sheehy director 415 MADISON AVENUE, 14TH FLOOR, NEW YORK NY 10017
Mark L. Portnoy director, officer: Co-Chief Executive Officer 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Harold D. Berger director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Arthur Ellis director 700 BROOKER CREEK BLVD, SUITE 1800, OLDSMAR FL 34677
Mary J Nyberg 10 percent owner 455 E MAYO BLVD, UNIT 5202, PHOENIX AZ 85050
Cdmj Nyberg Family Trust 10 percent owner 455 E MAYO BLVD, UNIT 5202, PHOENIX AZ 85050
Jill M Taymans officer: VP, Finance, CFO
Oleg Mikulinsky officer: Chief Information Officer 700 BROOKER CREEK BLVD., SUITE 1800, OLDSMAR FL 34677
Anthony Atala director 700 BROOKER CREEK BOULEVARD, OLDSMAR FL 34677
Scott G Christian director
Sung Won Sohn director 700 BROOKER CREEK BLVD., SUITE 1800, OLDSMAR FL 34677
Michael W. Cho director C/O IOWA STATE UNIVERSITY, 1600 S. 16TH STREET, AMES IA 50011-1250